You are here
Development of a Cytomegalovirus DNA Vaccine
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI058386-01
Agency Tracking Number: AI058386
Amount:
$263,787.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
10390 PACIFIC CENTER COURT
SAN DIEGO, CA
92121
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: THOMAS Evans
Phone: (858) 646-1158
Email: TEVANS@VICAL.COM
Phone: (858) 646-1158
Email: TEVANS@VICAL.COM
Business Contact
Phone: (858) 646-1108
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The specific AIM of this Phase I SBIR proposal from Vical Incorporated is to move forward an immunotherapeutic vaccine for cytomegalovirus (CMV) from preclinical to clinical development. Vical has undertaken a program
* Information listed above is at the time of submission. *